S3V Vascular Technologies Limited
- Unlisted share
- Healthcare
- ISIN INE0HGT01012
At a glance
Sales
FY24
₹14.93 Cr
−21.0%on FY23What the company earned from its customers in the year.
Loss for the year
FY24
₹-3.2 Cr
The company spent more than it earned in the year.
Market valuecalculated
₹720 Cr
What the whole company would be worth at GrowFast's indicative price.
From the company's published figures; sources are beside each figure further down the page.
Key details
- Company
- S3V Vascular Technologies Limited
- ISIN
- INE0HGT01012
- Sector
- Healthcare
- Type of share
- Unlisted equity share
- Indicative price per share
- ₹530.15
- Price last updated
- 12 Oct 2026
- Minimum quantity
- Confirmed by the desk
- How you hold it
- In your own demat account
- Enquiries
- GrowFast desk, on WhatsApp
Indicative prices, illiquid shares. Prices are indicative and can change without notice. Unlisted shares are illiquid: you may not be able to sell when you want to, or at the price shown.
Company
About S3V Vascular Technologies Limited
S3V Vascular Technologies Limited is a Mysuru-based maker of minimally invasive medical devices, chiefly cardiovascular products such as drug-eluting stents, with newer work in neurovascular and critical-care devices. It was incorporated in 2011, started commercial production in FY2013 and runs three plants in Mysuru; in 2025 the government's Technology Development Board agreed to support its planned stroke-thrombectomy device plant at the Oragadam medical devices park near Chennai. The company is promoted and run by the Nagarada Gadde family (N G Badari Narayan and relatives), and brought in outside investors through a preference-share issue in March 2024.
Written from: new.s3vvascular.com, new.s3vvascular.com, tdb.gov.in, acuite.in
Financials
Ask for the full annual report.
The figures on this page are the headline numbers. The desk can share the latest annual report and anything published since.
Ask for the financials- Sector
- Healthcare
- ISIN
- INE0HGT01012
- Registered office
- Hootagalli Industrial Area, Mysuru, Karnataka
- Promoters
- N G Badari Narayan (16.76%), Kalindhi Narayan (8.43%), N.G. Vijaya Gopal (6.12%), N.G. Vishnu Shreyas (5.05%) and N.G. Srivatsa Sarang (4.69%)
- Key people
- Managing Director: Vijaya Gopal Nagaradagadde; Whole Time Director & CEO: Badari Narayan Nagarada Gadde; Whole Time Director & CFO: Nagarada Gadde Vishnu Shreyas
- Face value per share
- ₹10
- Equity shares outstanding
- 1,35,89,284 shares
- Website
- new.s3vvascular.com
Read from: 13th Annual Report FY2023-24 (company website), unless another source is shown on a card.
Key data
What the numbers mean
The ratios buyers look at, each said in plain words.
Profit margincalculated
-21.4%
For every ₹100 of sales, the company lost ₹21.4.
- Indicative price
- ₹530.15
- Market valuecalculated
- ₹720 Cr
- price × shares
- No. of shares
- 1,35,89,284
- EPS
- ₹-2.37
- Face value
- ₹10
Figures marked “calculated” are worked out by GrowFast from its indicative price and the company's published figures for FY2023-24. They move with the price, and they are arithmetic, not a valuation.
Figures in ₹ crore
Financials
S3V Vascular Technologies Limited. As published in the company's audited reports. GrowFast has not audited them.
Sales, year by year
₹ crore. The darkest bar is the latest year.
FY22 to FY24: ₹20.91 Cr to ₹14.93 Cr.
Profit, year by year
₹ crore, after tax. A bar below the line is a loss.
FY22 to FY24: ₹2.68 Cr to ₹-3.2 Cr.
| Particulars | FY22 | FY23 | FY24Latest |
|---|---|---|---|
| Revenue from operations | 20.91 | 18.9 | 14.93▼21% |
| Other income | 0.1 | 0.08 | 0.23▲188% |
| Total income | 21 | 18.98 | 15.15▼20% |
| Depreciation and amortisation | 1.48 | 1.73 | 2.07▲20% |
| Finance costs | 1.4 | 1.31 | 3.56▲172% |
| Profit before tax | 2.8 | 0.65 | -3.06▼571% |
| Profit after tax | 2.68 | 0.56 | -3.2▼671% |
| Earnings per share (basic) (₹) | n/a | 0.43 | -2.37▼651% |
Rupees crore unless marked, standalone. The change shown is the latest year against the year before. Read from: 12th Annual Report FY2022-23 (company website), 13th Annual Report FY2023-24 (company website).
Ownership
Shareholding pattern
Who owns the company
As of 31 March 2024
16.8%N G Badari Narayan (promoter)
- Largest holder
- 16.8%
- Top 3 together
- 32.6%
- Holders named
- 7
- N G Badari Narayan (promoter)16.76%
- Kalindhi Narayan (promoter)8.43%
- L&T Welfare Company Limited (preference shares)7.41%
- N.G. Vijaya Gopal (promoter)6.12%
- Mahima Stocks Private Limited (preference shares)5.63%
- N.G. Vishnu Shreyas (promoter)5.05%
- N.G. Srivatsa Sarang (promoter)4.69%
- Total54.09%
Capital history
Fund raise history
| Date and detail | Type | Instrument | Price per share | Amount raised |
|---|---|---|---|---|
| 26 Mar 20244,80,123 CCPS of ₹10 issued at ₹176 each (premium ₹166). | Private placement | 0.01% non-cumulative compulsorily convertible preference shares | ₹176 | Not stated |
| 13 Mar 202451,09,183 CCPS of ₹10 issued at ₹176 each (premium ₹166) to investors. | Private placement | 0.01% non-cumulative compulsorily convertible preference shares | ₹176 | Not stated |
| 14 Sept 202328,410 equity shares at ₹176 each to existing shareholders. | Private placement | Equity shares | ₹176 | Not stated |
| 11 Aug 202328,410 equity shares at ₹176 each to new shareholders. | Private placement | Equity shares | ₹176 | Not stated |
| 8 Aug 20231,64,790 equity shares at ₹176 each to existing shareholders. | Private placement | Equity shares | ₹176 | Not stated |
| 15 Jul 20231,48,410 equity shares at ₹176 each to existing shareholders. | Private placement | Equity shares | ₹176 | Not stated |
Leadership
Management
Vijaya Gopal Nagaradagadde
Managing Director
Badari Narayan Nagarada Gadde
Whole Time Director & CEO
Nagarada Gadde Vishnu Shreyas
Whole Time Director & CFO
Veeresham Ciddi
Independent Director
Prithi Sureka Mummidi
Independent Director
Govindan Ramaswamy
Independent Director (from 15.04.2024)
Narendra Kumar Srisrimal
Non-executive and Non-Independent Director
Anuj Mehta
Company Secretary
Corporate calendar
Events
- 30 May 2025Government supportTechnology Development Board (DST) sanctions assistance for an integrated stroke-thrombectomy device plant at OragadamOpen
- 30 Sept 2024AGM13th AGM held at Mysuru; includes approval for investments, loans and guarantees up to ₹100 crore under section 186Open
- 26 Apr 2024EGMEGM to adopt amended articles following the investment agreement of 4 March 2024 with new investorsOpen
- 31 May 2022Credit ratingAcuité withdrew its 'ACUITE D' (issuer not co-operating) ratings on ₹28.33 crore of bank facilities at the company's request with banker's no-objectionOpen
Reports and filings
Annual reports and results
Each link opens the document where its publisher keeps it.
Before you buy
Six things to check on any unlisted share.
The same list applies to every stock. None of it is advice on this one.
The company's latest financials
Revenue, profit and debt for the last three years, from its audited annual report. Ask the desk for the most recent set.
What the price implies
Compare the price per share with earnings and book value per share, and with listed companies in the same business.
Whether a listing is planned
A company may file for an IPO, delay it or never list. A listing, its timing and its price are never certain.
How you would sell
There is no exchange for these shares. You sell by finding a buyer, which can take time and may be at a lower price.
Lock-in after a listing
Shares bought before an IPO are usually locked in for a period after the company lists. Confirm the current rule before you buy.
Tax on your gains
Unlisted shares are taxed differently from listed ones. Check your position with a tax adviser.
Questions
What buyers ask about this stock.
Not answered here? Ask the desk.
Inquire about S3V Vascular Technologies Limited on WhatsAppIs the price shown for S3V Vascular Technologies Limited final?
No. It is an indicative price per share. The desk confirms the price and the quantity available when you inquire, and the confirmed price is the one you deal at.
How do I buy these shares?
Press Inquire. It opens a WhatsApp chat with the desk, with this stock already named. After the price and quantity are agreed, a 10% advance locks the deal. Once your KYC is complete you pay the balance, and the shares are transferred to your demat account.
Do I pay anything on this website?
No. No payment is taken and no order is placed on this site. Payment details are shared by the desk only after the deal is agreed.
What do I need before I can buy?
A demat account in your name and the documents for KYC: your identity and demat account details are verified before any deal, as the regulations require.
Can I sell my S3V Vascular Technologies Limited shares to GrowFast?
GrowFast buys as well as sells. Press Inquire and tell the desk how many shares you hold; it will come back with what it can offer.
How do I sell S3V Vascular Technologies Limited shares I already hold?
Tell the desk how many you hold. If a price is agreed, you transfer the shares from your demat account with a delivery instruction to your depository participant (a DIS, or its online equivalent), and payment follows as agreed with the desk.
Is there a lock-in if the company lists?
Shares held before an IPO are generally locked in for a period after the listing under SEBI's rules, which have changed over time. Ask the desk for the rule that applies today before you buy.
Is buying unlisted shares legal in India?
Yes. Shares of an unlisted company can be bought and sold privately and are transferred between demat accounts. They are not traded on a stock exchange, so the protections of an exchange do not apply.
What is the minimum I can buy?
It differs by stock and by what the desk holds at the time. The desk confirms the minimum quantity when you inquire.
What is an ISIN?
The 12-character code that identifies a security. It is how your depository knows exactly which share is being transferred to your demat account.
Why are unlisted shares riskier than listed ones?
Prices are indicative and can change without notice. Unlisted shares are illiquid: you may not be able to sell when you want to, or at the price shown.
Similar stocks
More in Healthcare
- Anglo-French Drugs & Industries Ltd₹1,585.24 · ₹179 Cr · P/E 7.8
- API Holdings Ltd (PharmEasy)₹6.46 · ₹4,539 Cr
- Dantech Digital Dental Solutions Private Limited₹445.50
- Down Town Hospital Limited₹371.25
- Gynofem Healthcare and Pharmaceutical₹63.36
- Hicks Thermometers India Limited₹1,633.50 · ₹45 Cr · P/E 8.1
Risk disclosure
Prices on this site are indicative, quoted per share, and are not an offer to buy or sell. The price and quantity for any deal are confirmed by GrowFast's desk at the time you deal.
Unlisted, pre-IPO and delisted shares are not traded on a stock exchange. They are illiquid, their prices can move sharply, and you may be unable to sell them when you wish or at all. A company that is expected to list may not do so.
Nothing on this site is investment advice or a promise of returns. Past prices do not predict future prices. Consider your own circumstances, and take independent advice, before you invest.
Inquire opens a WhatsApp chat with GrowFast. No payment is taken and no order is placed on this site.
GrowFast is not affiliated with, sponsored by or endorsed by S3V Vascular Technologies Limited. Its name and logo belong to their owner and are shown only to identify the company. Figures about it come from published sources and have not been audited by GrowFast. See the Terms and Conditions.